Gefapixant: all 27 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• The Real-world Treatment Satisfaction by Gefapixiant in RCCRecruitingNCT06542484Not applicable
• Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic CoughRecruitingNCT05813223Early Phase 1
• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China ExtensionCompletedNCT04525885Phase 3Results posted
• Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)CompletedNCT04193202Phase 3Results posted
• Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)CompletedNCT04193176Phase 3Results posted
• Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039)CompletedNCT03882801Phase 1Results posted
• A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)CompletedNCT03696108Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)CompletedNCT03654326Phase 2Results posted
• Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)TerminatedNCT03569033Phase 2Results posted
• Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)CompletedNCT03482713Phase 2Results posted
• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)CompletedNCT03449147Phase 3Results posted
• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)CompletedNCT03449134Phase 3Results posted
• The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)CompletedNCT03108924Phase 1Results posted
• An 8-Week Refractory Chronic Cough Study (MK-7264-021)CompletedNCT02612623Phase 2Results posted
• A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)CompletedNCT02612610Phase 2Results posted
• A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)CompletedNCT02502097Phase 2Results posted
• A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02477709Phase 2Results posted
• Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)CompletedNCT02476890Phase 2Results posted
• Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015)CompletedNCT02397460Phase 2Results posted
• A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010)CompletedNCT02349425Phase 2Results posted
• A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009)CompletedNCT01993329Phase 2Results posted
• The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Bladder Pain Syndrome (MK-7264-005)TerminatedNCT01569438Phase 2Results posted
• A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the KneeCompletedNCT01554579Phase 2Results posted
• A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)CompletedNCT01432730Phase 2Results posted
• A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) FormulationsCompletedNCT02790840Phase 1
• A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) FormulationsCompletedNCT02492776Phase 1
• A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)CompletedNCT02229877Phase 1

← Gefapixant overview